Creating a virtual agent to support MedTech innovators
07 Jun 2022
Yes
-  

 

 

The Science and Technology Facilities Council (STFC) Hartree Centre worked with Chilton Computing as part of an Innovate UK funded project to create a virtual agent that helps innovators navigate the medical device regulation space.

Yes

(​Source: Pexels)

 

Pexels Healthcare Virtaul assistant.jpg

Challenge

The COVID-19 pandemic has accelerated the development of a spectrum of new medical devices ranging from in vitro lateral flow tests to products powered by AI and Internet of Things (IoT) technologies. For innovators, the strict and evolving regulatory requirements governing medical product development are challenging to navigate. With new regulations coming into force from the EU and certifications introduced for UK products, there is a growing demand for expertise to help innovators transition into, understand and keep up with requirements to get their devices approved in time for market launch.

Approach

The Hartree Centre’s Research Software Engineering team used their expertise in AI and natural language processing to create a chatbot – the first for use in the regulatory space – to complement the Nav.AI tool developed by Chilton Computing. The chatbot is capable of covering a broad spectrum of queries and generic questions on the regulatory process as a whole, signposting users to help them get the most out of the Nav.AI tool. By adopting an AI-driven approach to gather, process and link data, they were also able to automate the process of identifying the relevant information and connecting it to help with specific regulatory assessment tasks.

Benefits

This work not only benefits innovators who need support navigating and making sense of a crowded and potentially overwhelming regulatory space, but it also unlocks the power of conversational AI to capture contextual information from the questions that are asked of the chatbot. This information is used to help Chilton Computing to accelerate the development of their tool, building on previous iterations to help users get the most out of it and ensuring quality, timely support is available for medical innovators. This combination strengthens the overall market offering of the Nav.AI tool contributing overall competitiveness as the company look to expand into international markets.


"This has enabled us to explore the potential of conversational AI, opening up new ways to capture and act upon contextual information to provide a better and more powerful user experience, accelerating the development of our tool."

Erica Yang

Chilton Computing​

Download as a PDF


Contact: